EUVIMEDEUVIMED entdecken
Open Access

Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?

Harisan Nasir, Benjamin E Berkman, Leila Jamal, Chloe Connor, Anya E R Prince

Journal of Law and the Biosciences · 12.02.2026 · 13 (1)

DOI: 10.1093/jlb/lsag017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Law and the Biosciences, online erschienen am 14.05.2026. Verfasst von Harisan Nasir und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioethics, National Institutes of Health, Washington, DC, USA. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Whether life insurers should be able to consider genetic information during underwriting is a long-standing debate often characterized by strong opinions on both sides. Insurers push for full access to applicants’ genetic information, and consumer advocates often call for a ban on insurer use of the information. Both sides employ concepts of fairness and discrimination in supporting their position. This article considers the concept of actuarial fairness, where individuals are expected to pay for the risks they bring to an insurance pool. Currently, law and policy adopting this standard most often take a deferential approach, allowing insurers to utilize genetic information with wide latitude. This article takes seriously a middle-ground approach, broadly labeled as actuarial utility. Building from prior literature examining this issue, this article proposes a framework US policy can adopt to assist in the assessment of the actuarial utility of genetic information with a particular focus on emerging genetic technologies.

Schlagwörter

Stichwörter der Autor:innen

actuarial justificationdiscriminationfairnessgeneticsinsuranceunderwriting

Autor:innen und Institutionen

  • Department of Bioethics, National Institutes of Health, Washington, DC, USA.
  • Centre for Biomedical Ethics, National University Singapore, Singapore.
  • National Human Genome Research Institute, National Institutes of Health, Washington, DC, USA.
  • Center for Cancer Research, National Cancer Institute, National Institutes of Health, Washington, DC, USA.
  • University of Iowa College of Law, Iowa City, IA, USA.

Zitieren

APA

Nasir, H., Berkman, B. E., Jamal, L., Connor, C., & Prince, A. E. R. (2026). Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?. Journal of Law and the Biosciences, 13(1). https://doi.org/10.1093/jlb/lsag017

Vancouver

Nasir H, Berkman BE, Jamal L, Connor C, Prince AER. Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?. Journal of Law and the Biosciences. 2026;13(1). doi:10.1093/jlb/lsag017

BibTeX
@article{Nasir2026,
  author = {Nasir, Harisan and Berkman, Benjamin E and Jamal, Leila and Connor, Chloe and Prince, Anya E R},
  title = {Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?},
  journal = {Journal of Law and the Biosciences},
  year = {2026},
  volume = {13},
  number = {1},
  doi = {10.1093/jlb/lsag017}
}
Kostenlos starten →